CDK9 Inhibitors

CDK1

CDK2

CDK3

CDK4

CDK5

CDK6

CDK7

CDK8

CDK9

CDK11

CDK12

CDK13

CDK14

CDK16

CDK19

CDC

CLK

CDK9 Specific Inhibitors

Product Name	CDK9	CDK1	CDK2	CDK3	CDK4	CDK5	CDK6	CDK7	CDK8	CDK14	CDK16	CDK19	CDK9 Selectivity	Purity
NVP-2	CDK9, IC₅₀: 0.5 nM												Selective Inhibitor	99.29%
AZD4573	CDK9, IC₅₀: 3 nM												Selective Inhibitor	99.80%
(+)-BAY-1251152	CDK9, IC₅₀: 3 nM												Selective Inhibitor	99.66%
PHA-767491 hydrochloride	CDK9, IC₅₀: 34 nM	CDK1, IC₅₀: 250 nM	CDK2, IC₅₀: 240 nM			CDK5, IC₅₀: 460 nM							Selective Inhibitor	99.91%
LDC000067	CDK9- Cyclin T1, IC₅₀: 44 nM	cdk1-cyclin B1, IC₅₀: 5513 nM	cdk2-cyclin A, IC₅₀: 2441 nM		cdk4-cyclin D1, IC₅₀: 9242 nM								Selective Inhibitor	98.14%
Atuveciclib	CDK9/CycT1, IC₅₀: 13 nM CDK9/CycT1(h), IC₅₀: 6 nM	CDK1/CycB(h), IC₅₀: 1100 nM	CDK2/CycE(h), IC₅₀: 1000 nM	CDK3/CycE(h), IC₅₀: 890 nM		CDK5/p35(h), IC₅₀: 1600 nM							Selective Inhibitor	99.42%
CDK9-IN-1	CDK9/CycT1, IC₅₀: 39 nM												Selective Inhibitor	95.48%
PROTAC CDK9 Degrader-1	CDK9												Selective Inhibitor	99.04%
MC180295	CDK9- Cyclin T1, IC₅₀: 5 nM	CDK1-Cyclin B, IC₅₀: 138 nM	cdk2-cyclin A, IC₅₀: 233 nM cdk2-cyclin E, IC₅₀: 367 nM	CDK3-Cyclin E, IC₅₀: 399 nM	CDK4-Cyclin D, IC₅₀: 112 nM	cdk5-p35, IC₅₀: 159 nM cdk5-p25, IC₅₀: 186 nM	cdk6-cyclin D3, IC₅₀: 712 nM	CDK7-CycH/MAT1, IC₅₀: 555 nM					Selective Inhibitor	98.47%
CDK-IN-2	CDK9/cyclinT1, IC₅₀: 8 nM												Selective Inhibitor	97.54%
JSH-150	CDK9/cyclinT1, IC₅₀: 1 nM	Cdk1/cyclin B, IC₅₀: 1.34 μM	cdk2/cyclin A, IC₅₀: 2.86 μM			Cdk5/p25, IC₅₀: 4.64 μM		CDK7/Cyclin H/MNAT1, IC₅₀: 1.72 μM		CDK14/Cyclin Y, IC₅₀: 1.68 μM	CDK16/Cyclin Y, IC₅₀: 292 nM		Selective Inhibitor	92.04%
CDK9 Antagonist-1	CDK9, IC₅₀: 17 μM (MCF-7 cells)												Selective Inhibitor
CDK9-IN-7	CDK9/cyclinT1, IC₅₀: 11 nM				CDK4/cyclin D, IC₅₀: 148 nM		CDK6/cyclinD, IC₅₀: 145 nM						Selective Inhibitor
CDK9-IN-8	CDK9, IC₅₀: 12 nM												Selective Inhibitor
PHA-767491	CDK9, IC₅₀: 34 nM	CDK1, IC₅₀: 250 nM	CDK2, IC₅₀: 240 nM			CDK5, IC₅₀: 460 nM							Selective Inhibitor
Abemaciclib methanesulfonate	CDK9/cyclinT1, IC₅₀: 57 nM	CDK1/cyclinB1, IC₅₀: 1627 nM	CDK2/cyclinE, IC₅₀: 504 nM		Cdk4/cyclin D1, IC₅₀: 2 nM	Cdk5/p25, IC₅₀: 355 nM CDK5/p35, IC₅₀: 287 nM	CDK6/cyclinD1, IC₅₀: 10 nM	CDK7/Mat1/cyclinH1, IC₅₀: 3910 nM					Pan Inhibitor	99.95%
Dinaciclib	CDK9, IC₅₀: 4 nM	CDK1, IC₅₀: 3 nM	CDK2, IC₅₀: 1 nM			CDK5, IC₅₀: 1 nM							Pan Inhibitor	99.73%
CYC065	CDK9		CDK2										Pan Inhibitor	99.78%
Abemaciclib	CDK9/cyclinT1, IC₅₀: 57 nM	CDK1/cyclinB1, IC₅₀: 1627 nM	CDK2/cyclinE, IC₅₀: 504 nM		Cdk4/cyclin D1, IC₅₀: 2 nM	CDK5/p35, IC₅₀: 287 nM Cdk5/p25, IC₅₀: 355 nM	CDK6/cyclinD1, IC₅₀: 10 nM	CDK7/Mat1/cyclinH1, IC₅₀: 3910 nM					Pan Inhibitor	99.69%
Atuveciclib Racemate	CDK9												Pan Inhibitor	98.48%
SNS-032	CDK9, IC₅₀: 4 nM	CDK1, IC₅₀: 480 nM	CDK2, IC₅₀: 38 nM		CDK4, IC₅₀: 925 nM			CDK7, IC₅₀: 62 nM					Pan Inhibitor	98.50%
AZD-5438	cdk9-cyclin T, IC₅₀: 20 nM	cdk1-cyclin B1, IC₅₀: 16 nM	cdk2-cyclin E, IC₅₀: 6 nM cdk2-cyclin A, IC₅₀: 45 nM		cdk4-cyclin D1, IC₅₀: 449 nM	cdk5-p25, IC₅₀: 14 nM	cdk6-cyclin D3, IC₅₀: 21 nM	cdk7-cyclin H, IC₅₀: 821 nM					Pan Inhibitor	99.37%
AT7519	CDK9/Cyclin T, IC₅₀: 10 nM	Cdk1/cyclin B, IC₅₀: 210 nM	cdk2/cyclin A, IC₅₀: 47 nM		Cdk4/cyclin D1, IC₅₀: 100 nM	CDK5/p35, IC₅₀: 13 nM	cdk6/cyclin D3, IC₅₀: 170 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2400 nM					Pan Inhibitor	98.15%
CDKI-73	CDK9, IC₅₀: 5.78 nM	CDK1, IC₅₀: 8.17 nM	CDK2, IC₅₀: 3.27 nM		CDK4, IC₅₀: 8.18 nM		CDK6, IC₅₀: 37.68 nM	CDK7, IC₅₀: 134.26 nM					Pan Inhibitor	99.58%
AT7519 Hydrochloride	CDK9/Cyclin T, IC₅₀: 10 nM	Cdk1/cyclin B, IC₅₀: 210 nM	cdk2/cyclin A, IC₅₀: 47 nM		Cdk4/cyclin D1, IC₅₀: 100 nM	CDK5/p35, IC₅₀: 13 nM	cdk6/cyclin D3, IC₅₀: 170 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2400 nM					Pan Inhibitor	99.99%
LY2857785	CDK9, IC₅₀: 0.011 μM							CDK7, IC₅₀: 0.246 μM	CDK8, IC₅₀: 0.016 μM				Pan Inhibitor	98.59%
SEL120-34A HCl	CDK9/cycT, IC₅₀: 1070 nM								CDK8/CycC, IC₅₀: 4.4 nM			CDK19/CycC, IC₅₀: 10.4 nM	Pan Inhibitor	99.80%
SEL120-34A monohydrochloride	CDK9/cycT, IC₅₀: 1070 nM								CDK8/CycC, IC₅₀: 4.4 nM			CDK19/CycC, IC₅₀: 10.4 nM	Pan Inhibitor	99.98%
Lerociclib dihydrochloride	CDK9/Cyclin T, IC₅₀: 28 nM	CDK1/cyclinB1, IC₅₀: 2.4 μM	cdk2/cyclin A, IC₅₀: 1.5 μM CDK2/cyclinE, IC₅₀: 3.6 μM		Cdk4/cyclin D1, IC₅₀: 1 nM	CDK5/p35, IC₅₀: 832 nM Cdk5/p25, IC₅₀: 1.2 μM	cdk6/cyclin D3, IC₅₀: 2 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2.4 μM					Pan Inhibitor	98.45%
NVP-LCQ195	CDK9/cyclinT1, IC₅₀: 15 nM	Cdk1/cyclin B, IC₅₀: 2 nM	cdk2/cyclin A, IC₅₀: 2 nM CDK2/cyclinE, IC₅₀: 5 nM	CDK3/Cyclin E, IC₅₀: 42 nM		Cdk5/p25, IC₅₀: 1 nM CDK5/p35, IC₅₀: 1 nM	cdk6/cyclin D3, IC₅₀: 187 nM	CDK7/Cyclin H/MAT1, IC₅₀: 3564 nM					Pan Inhibitor	98.99%
Voruciclib hydrochloride	CDK9/CycT1, Ki: 1.68 nM CDK9/cyc T2, Ki: 0.626 nM	CDK1/cycB, Ki: 5.4 nM CDK1/cyc A, Ki: 9.1 nM			CDK4/Cyc D1, Ki: 3.96 nM		CDK6/cycD1, Ki: 2.92 nM						Pan Inhibitor
AT7519 trifluoroacetate	CDK9/Cyclin T, IC₅₀: 10 nM	Cdk1/cyclin B, IC₅₀: 210 nM	cdk2/cyclin A, IC₅₀: 47 nM		Cdk4/cyclin D1, IC₅₀: 100 nM	CDK5/p35, IC₅₀: 13 nM	cdk6/cyclin D3, IC₅₀: 170 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2400 nM					Pan Inhibitor	98.16%
SEL120-34A	CDK9/cycT, IC₅₀: 1070 nM								CDK8/CycC, IC₅₀: 4.4 nM			CDK19/CycC, IC₅₀: 10.4 nM	Pan Inhibitor
Roniciclib	CDK9/cyclinT1, IC₅₀: 5 nM	Cdk1/cyclin B, IC₅₀: 7 nM	CDK2/cyclinE, IC₅₀: 9 nM		CDK4/cyclin D, IC₅₀: 11 nM			CDK7/Cyclin H/MAT1, IC₅₀: 25 nM					Pan Inhibitor
BS-181 hydrochloride	CDK9/cycT, IC₅₀: 4.2 μM	CDK1/cycB, IC₅₀: 8.1 μM	CDK2/Cyc E, IC₅₀: 0.88 μM		CDK4/Cyc D1, IC₅₀: 33 μM	CDK5/p35NCK, IC₅₀: 3 μM	CDK6/cycD1, IC₅₀: 47 μM	CDK7/CycH/MAT1, IC₅₀: 0.021 μM					Pan Inhibitor
CDK8/19-IN-1	CDK9, IC₅₀: 270 nM								CDK8/CycC, IC₅₀: 0.46 nM			CDK19/CycC, IC₅₀: 0.99 nM	Pan Inhibitor
Riviciclib hydrochloride	CDK9- Cyclin T1, IC₅₀: 0.020 μM CDK9-cyclin H, IC₅₀: 2.900 μM	CDK1-Cyclin B, IC₅₀: 0.079 μM	cdk2-cyclin A, IC₅₀: 0.224 μM cdk2-cyclin E, IC₅₀: 2.500 μM		cdk4-cyclin D1, IC₅₀: 0.063 μM		cdk6-cyclin D3, IC₅₀: 0.396 μM						Pan
IIIM-290	CDK9/T1, IC₅₀: 94 nM		CDK2/A, IC₅₀: 90 nM										Pan Inhibitor
Riviciclib	CDK9- Cyclin T1, IC₅₀: 0.020 μM CDK9-cyclin H, IC₅₀: 2.900 μM	CDK1-Cyclin B, IC₅₀: 0.079 μM	cdk2-cyclin A, IC₅₀: 0.224 μM cdk2-cyclin E, IC₅₀: 2.540 μM		cdk4-cyclin D1, IC₅₀: 0.063 μM		cdk6-cyclin D3, IC₅₀: 0.396 μM						Pan Inhibitor
Lerociclib	CDK9/Cyclin T, IC₅₀: 28 nM	CDK1/cyclinB1, IC₅₀: 2.4 μM	cdk2/cyclin A, IC₅₀: 1.5 μM CDK2/cyclinE, IC₅₀: 3.6 μM		Cdk4/cyclin D1, IC₅₀: 1 nM	CDK5/p35, IC₅₀: 0.832 μM Cdk5/p25, IC₅₀: 1.2 μM	cdk6/cyclin D3, IC₅₀: 2 nM	CDK7/Cyclin H/MAT1, IC₅₀: 2.4 μM					Pan Inhibitor
(-)-BAY-1251152	CDK9												default Inhibitor	99.82%

Name
Email *

	Sorry, but the email address you supplied was invalid.